In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
400 News Items found
A researcher working in an MSK lab
MSK Research Highlights, April 23, 2025

New MSK research identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife. MSK clinical trials also supported the recent approval of the targeted drug larotrectinib by the FDA.
Perry Ortiz surrounded by his wife, daughter, and two sons
Celebrating Hispanic and Latino Heritage Month: Perry Ortiz

Perry Ortiz doesn’t remember having a seizure in 2016. Or being rushed to an operating room, where doctors confirmed Perry — a security supervisor at M...
A lab coat with an MSK logo hangs on a hook
Meet the 2025 Graduates of the Gerstner Sloan Kettering Graduate School

Fourteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 14, 2025, as part of Memorial Sloan Kettering’s 46th annual academic convocation.
Scientists Jan Remsik, Adrienne Boire, and Jessica Wilcox in the lab
Finding
MSK Researchers Learn What’s Driving ‘Brain Fog’ in People with COVID-19

The presence of inflammatory molecules in the cerebrospinal fluid appears to be causing many of the neurologic effects seen in people with COVID-19.
Medical oncologist Bill Tap examines a patient
Feature
Outsmarting Sarcoma: How MSK’s Experts Are Advancing Treatment and Research Progress

Spend a day with the expert team in MSK's world-renowned sarcoma service.
A researcher working in an MSK lab
MSK Research Highlights, March 26, 2025

New MSK research develops a new tool for studying mitochondrial DNA deletions; uncovers mechanisms of histiocytosis-associated neurodegeneration; and investigates how mutant stem cells co-opt regeneration to make tumors grow.
Linde Miles
Q&A
Meet Linde Miles, Winner of a Kravis WISE Postdoctoral Fellowship

Dr. Miles is a postdoctoral fellow in the Human Oncology and Pathogenesis Program at MSK studying the genetics of blood cancers.
MSK Kids neuroblastoma patient Abby Hawk
The Tale of Abby's Tattoo: How She Beat Neuroblastoma

Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma.
Michael Roehrl
‘Long COVID’: MSK Scientists Search for Potential Autoimmune Causes

A new resource provides a comprehensive list of human proteins that could trigger autoimmune symptoms in ‘long COVID’ patients.
Memorial Sloan Kettering Researchers Build a New Model of Genetically Engineered Immune Cells That May Combat Solid Tumors in the Future

Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.